Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Paul Tebbey"'
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 440-446 (2023)
Checkpoint inhibitors (CIs) are now standard of care for late-stage non-small-cell lung cancer (NSCLC); however, only a minority of patients treated with a CI show clinical benefit compared to platinum-based chemotherapy alone, regardless of programm
Externí odkaz:
https://doaj.org/article/c073b8672bd74df380eeb6911c75f383
Publikováno v:
Expert Opinion on Biological Therapy. 16:1445-1453
Loss of exclusivity for biological therapeutics opens the door for biosimilar development. Biosimilars must demonstrate structural, functional, and clinical similarity with a currently approved biological originator product. A therapeutic alternative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02284aec0307fe59bfcf91e3d6bda7de
https://doi.org/10.1080/14712598.2017.1238454
https://doi.org/10.1080/14712598.2017.1238454